ACRES Commercial Realty Corp., a real estate investment trust (REIT), focuses on the origination, holding, and management of commercial real estate mortgage loans and equity investments in commercial real estate property in the United States. The company invests in commercial real estate credit investments, including floating-rate first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine financing, preferred equity investments, and CRE equity investments. It qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as Exantas Capital Corp. and changed its name to ACRES Commercial Realty Corp. in February 2021. ACRES Commercial Realty Corp. was incorporated in 2005 and is based in Uniondale, New York.

ACRES Commercial Realty Corp.

American Clean Resources Group ( ($ACRG) ) has released a notification of late filing. American Clean Resources Group, Inc. has filed a Form 12b-25...

American Clean Resources Group Delays Quarterly Filing

Oppenheimer analyst reiterated a Buy rating on Acrivon Therapeutics, Inc. today and set a price target of $8.00. Acrivon Therapeutics, Inc. has an ...

Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer

Piper Sandler analyst Biren Amin maintained a Buy rating on Aclaris Therapeutics today and set a price target of $11.00. According to TipRanks, Ami...

Aclaris Therapeutics (ACRS) Gets a Buy from Piper Sandler

Guggenheim analyst Seamus Fernandez reiterated a Buy rating on Aclaris Therapeutics today and set a price target of $12.00. According to TipRanks, ...

Guggenheim Keeps Their Buy Rating on Aclaris Therapeutics (ACRS)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Medline (MDLN), Aclaris Therapeutics (ACRS) and Alkermes (ALKS). ...

Analysts Offer Insights on Healthcare Companies: Medline (MDLN), Aclaris Therapeutics (ACRS) and Alkermes (ALKS)

Acrux ( ($AU:ACR) ) just unveiled an announcement. Acrux Limited has outlined plans for a fresh capital raise via a placement or similar securities...

Acrux Plans Major Equity Issue to Bolster Capital Base

Acrux ( ($AU:ACR) ) has issued an announcement. Acrux Limited has raised $1.6 million via a share placement to institutional and professional inves...

Acrux Secures $1.6m Placement to Advance Female Testosterone Program

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Silence Therapeutics (SLN), Aclaris Therapeutics (AC...

Analysts’ Top Healthcare Picks: Silence Therapeutics (SLN), Aclaris Therapeutics (ACRS)

Oppenheimer analyst Jeff Jones reiterated a Buy rating on Aclaris Therapeutics today and set a price target of $10.00. Jones covers the Healthcare ...

Aclaris Therapeutics (ACRS) Gets a Buy from Oppenheimer

Craig-Hallum analyst Adam Vogel maintained a Buy rating on Aclaris Therapeutics today and set a price target of $10.00. Vogel covers the Healthcare...

Aclaris Therapeutics (ACRS) Gets a Buy from Craig-Hallum

Ares Commercial ( ($ACRE) ) has provided an update. On May 7, 2026, Ares Commercial Real Estate Corporation reported first-quarter 2026 results sho...

Ares Commercial Reports Q1 Loss, Maintains Dividend Payouts

Acres Commercial Realty Corp. (($ACR)) has held its Q1 earnings call. Read on for the main highlights of the call. Acres Commercial Realty Corp.’s ...

Acres Commercial Realty Highlights Growth Amid Tight Liquidity

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Indivior (INDV), Aclaris Therapeutics (ACRS) and Com...

Analysts Are Bullish on Top Healthcare Stocks: Indivior (INDV), Aclaris Therapeutics (ACRS)

Bernstein analyst Sabrina Blanc maintained a Buy rating on Accor SA yesterday. The company’s shares closed last Friday at €42.89. According to TipR...

Bernstein Reaffirms Their Buy Rating on Accor SA (0H59)

Kepler Capital analyst Julien Richer maintained a Buy rating on Accor SA on April 20 and set a price target of €52.00. The company’s shares closed ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ACR	$19.63	+0.31%	10.69K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ACR	$19.63	+0.3%	10.69K
3
4
5
6

ACR

ACR

Get ACRES Commercial Realty Corp. Data in Excel

Get ACRES Commercial Realty Corp. Data in Excel